HORMONE THERAPY IN ADVANCED ER+/HER2- NEGATIVE BREAST CANCER WITH PI3K INHIBITORS: A REVIEW OF THE LITERATURE

Breast cancer is a heterogenous disease, showing as several different clinical and histologic types. Most of breast cancers express hormone receptors for estrogen and progesterone, which are considered as estrogen receptor-positive and progesterone-receptor-positive, respectively. Endocrine thera...

Full description

Bibliographic Details
Main Authors: Ivan Inkov, Desislava Penkova, George Baytchev, Zdravko Kamenov, Mila Kayriakova, Dimo Manov
Format: Article
Language:English
Published: Bulgarian Association of Young Surgeons 2016-08-01
Series:International Journal of Surgery and Medicine
Online Access:http://dx.doi.org/10.5455/ijsm.pi3kinhibitorbreastcancer